July 1, 2026, (Inside AI) — Cigna's health services arm Evernorth launched Pharmacy Forward, an AI-powered specialty pharmacy program, backed by a $100 million investment through 2028. The initiative aims to slash prescription processing times and elevate customer service for patients on complex, high-cost medications.
The program embeds artificial intelligence into core pharmacy workflows, targeting the notoriously slow and manual processes that plague specialty drug dispensing. By automating prior authorizations, benefits verification, and clinical reviews, Evernorth expects to cut wait times from days to hours.
Specialty pharmacies handle medications for chronic, rare, or complex conditions—think cancer, multiple sclerosis, or rheumatoid arthritis. These drugs often require refrigeration, strict handling, and extensive paperwork. Delays can mean disease progression. Cigna’s move directly addresses a friction point that costs the U.S. healthcare system billions annually in administrative waste.
Evernorth, formed in 2020, already manages over 100 million patient relationships. Its scale gives the AI models a vast training ground. The system will learn from millions of prior authorization cases, claims data, and clinical outcomes to predict approvals and flag risks faster than human teams.
“Pharmacy Forward is about removing barriers between patients and the medicines they need,” said an Evernorth spokesperson, though no named executive was quoted in the initial announcement. The company has been quietly piloting AI tools since 2024, focusing on reducing the 40% of specialty prescriptions that face initial delays due to administrative hurdles.
AI’s Quiet Revolution in the Back Office
While consumer AI grabs headlines, healthcare’s biggest ROI hides in unglamorous infrastructure. Prior authorization alone costs the U.S. healthcare system over $35 billion annually, per a 2023 JAMA study. Insurers like Cigna see AI not as a novelty but as a margin protector in a sector where administrative costs devour 15-30% of health spending.
Cigna’s investment follows similar moves by UnitedHealth Group and CVS Health, which have deployed AI for claims review and pharmacy benefit management. However, specialty pharmacy presents unique challenges: each drug may have dozens of clinical criteria, and errors can cause life-threatening delays. The stakes force a more cautious AI rollout than, say, retail chatbots.
Critics warn that AI-driven prior auth could become a black box, rubber-stamping denials without human empathy. The American Medical Association has repeatedly called for transparency in automated utilization management. Evernorth insists its system will augment, not replace, clinical pharmacists, but details on human override rates remain undisclosed.
The $100 Million Bet on Speed and Scale
The $100 million will fund technology development, integration with electronic health records, and staff retraining. Evernorth plans to deploy the system across its network of specialty pharmacies, which dispense over 30 million prescriptions yearly. The investment signals a long-term shift from labor-intensive operations to algorithmically optimized workflows.
Industry analysts note that specialty pharmacy is the fastest-growing drug spending category, projected to hit $400 billion by 2030. Insurers that master AI-driven efficiency could gain a decisive competitive edge. Cigna’s stock was flat on the news, suggesting investors already priced in such modernization efforts.
Missing from the announcement are concrete metrics: how much faster will processing become? What error rates are expected? And how will patient satisfaction be measured? Without these, the program risks being lumped with vague “AI transformation” promises that litter corporate press releases.
Still, the move underscores a broader truth: healthcare’s AI revolution won’t be led by robot surgeons but by algorithms quietly untangling the administrative knot that binds doctors and patients. Pharmacy Forward may not be flashy, but if it works, it could become a blueprint for an industry desperate to cut costs without sacrificing care.
